Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.42 USD | -0.71% | -0.53% | -37.18% |
Financials (USD)
Sales 2024 * | 462M | Sales 2025 * | 526M | Capitalization | 1.08B |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -28M | EV / Sales 2024 * | 2.21 x |
Net cash position 2024 * | 63.34M | Net cash position 2025 * | 76.49M | EV / Sales 2025 * | 1.92 x |
P/E ratio 2024 * |
-28.8
x | P/E ratio 2025 * |
-36.9
x | Employees | 1,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.79% |
Latest transcript on AtriCure, Inc.
1 day | -0.71% | ||
1 week | -0.53% | ||
Current month | -0.53% | ||
1 month | +2.51% | ||
3 months | -39.68% | ||
6 months | -32.95% | ||
Current year | -37.18% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Angela Wirick
DFI | Director of Finance/CFO | 46 | 14-06-30 |
Chief Tech/Sci/R&D Officer | 52 | 17-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 19-12-03 |
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Sven Wehrwein
BRD | Director/Board Member | 73 | 16-11-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 415 M€ | -.--% | ||
0.03% | 775 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 22.42 | -0.71% | 305,569 |
24-06-06 | 22.58 | +1.71% | 704,450 |
24-06-05 | 22.2 | -1.38% | 554,564 |
24-06-04 | 22.51 | +0.40% | 479,660 |
24-06-03 | 22.42 | -0.53% | 589,317 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.18% | 1.08B | |
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
+16.92% | 25.62B | |
-6.87% | 23.32B |
- Stock Market
- Equities
- ATRC Stock